Article: New bill to curb sales of pseudoephedrine to be unveiled.

Byline: Deirdre Shesgreen

WASHINGTON _ On a bitterly cold February morning, a half dozen lobbyists filed into Sen. Jim Talent's conference room for a tense, 90-minute meeting with one of the Missouri lawmaker's top aides.

The lobbyists represented an array of powerful business interests, from deep-pocketed drug companies to retail giants such as Wal-Mart and Target to the nation's convenience store industry. They were there to talk about a bill Talent, R-Mo., and Sen. Dianne Feinstein, D- Calif., had introduced three weeks earlier proposing sharp new curbs on the sale of popular cold medicines containing a key ingredient used to make methamphetamine.

...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!